Paclitaxel therapeutic drug monitoring - International association of therapeutic drug monitoring and clinical toxicology recommendations
European Journal of Cancer · 2024-05 · 202 · 114024
DOI: 10.1016/j.ejca.2024.114024 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Cancer, 2024-05. Verfasst von Daniel L Hertz und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, University of Michigan College of Pharmacy, University of Michigan, Ann Arbor, MI, USA. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, University of Michigan College of Pharmacy, University of Michigan, Ann Arbor, MI, USA.
- Department of Medical Oncology & Hematology, Cantonal Hospital, St. Gallen, Switzerland. Electronic address: markus.joerger@kssg.ch.
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul, South Korea.
- Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.
- Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
- Department of Medical Oncology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, China.
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Hertz, D. L., Joerger, M., Bang, Y. J., Mathijssen, R. H., Zhou, C., Zhang, L., Gandara, D., Stahl, M., Monk, B. J., Jaehde, U., & Beumer, J. H. (2024). Paclitaxel therapeutic drug monitoring - International association of therapeutic drug monitoring and clinical toxicology recommendations. European Journal of Cancer, 202, 114024. https://doi.org/10.1016/j.ejca.2024.114024
Vancouver
Hertz DL, Joerger M, Bang YJ, Mathijssen RH, Zhou C, Zhang L, et al. Paclitaxel therapeutic drug monitoring - International association of therapeutic drug monitoring and clinical toxicology recommendations. European Journal of Cancer. 2024;202:114024. doi:10.1016/j.ejca.2024.114024
BibTeX
@article{Hertz2024,
author = {Hertz, Daniel L and Joerger, Markus and Bang, Yung-Jue and Mathijssen, Ron H and Zhou, Caicun and Zhang, Li and Gandara, David and Stahl, Michael and Monk, Bradley J and Jaehde, Ulrich and Beumer, Jan H},
title = {Paclitaxel therapeutic drug monitoring - International association of therapeutic drug monitoring and clinical toxicology recommendations},
journal = {European Journal of Cancer},
year = {2024},
volume = {202},
pages = {114024},
doi = {10.1016/j.ejca.2024.114024}
}
EUVIMED